Genomic landscape of pleural and peritoneal mesothelioma tumours.
Stefanie HiltbrunnerZoe FleischmannEthan S SokolMartin ZocheEmanuela Felley-BoscoAlessandra Curioni-FontecedroPublished in: British journal of cancer (2022)
Here, we report the molecular aberrations from the largest cohort of patients with mesothelioma. This analysis identified a proportion of patients with targetable alterations and suggests that molecular profiling can identify new treatment options for patients with mesothelioma.